Release Date: 26/02/09 11:30 Summary: Full Year Results 2008 Price Sensitive: Yes Download Document 1013.33KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%